TITANIUM DIOXIDE

TITANIUM DIOXIDE was reported 243 times

These side effects are most commonly reported by patients taking TITANIUM DIOXIDE:

# Side effect Count
0 HYPERSENSITIVITY 23
1 ABDOMINAL PAIN UPPER 17
2 RASH 17
3 ERYTHEMA 16
4 ACNE 13
5 MADAROSIS 13
6 REACTION TO EXCIPIENT 13
7 OFF LABEL USE 11
8 DRUG HYPERSENSITIVITY 10
9 DYSPNOEA 10
10 HEADACHE 10
11 PAIN 10
12 RASH ERYTHEMATOUS 10
13 SWELLING FACE 10
14 CONDITION AGGRAVATED 9
15 FATIGUE 9
16 NAUSEA 9
17 PAIN IN EXTREMITY 9
18 SUNBURN 9
19 DEATH 8
20 DRY SKIN 8
21 MALIGNANT MELANOMA 8
22 PRURITUS 8
23 DIARRHOEA 7
24 DRUG INEFFECTIVE 7
25 DRY MOUTH 7
26 INTENTIONAL PRODUCT MISUSE 7
27 PHOTOSENSITIVITY REACTION 7
28 PSORIASIS 7
29 SOMNOLENCE 7
30 ABDOMINAL DISTENSION 6
31 APPLICATION SITE ERYTHEMA 6
32 BASAL CELL CARCINOMA 6
33 CHEST PAIN 6
34 DEPRESSION 6
35 DERMATITIS 6
36 DRUG INTOLERANCE 6
37 MALAISE 6
38 PRODUCT USE ISSUE 6
39 RASH MACULAR 6
40 RESTLESS LEGS SYNDROME 6
41 URTICARIA 6
42 ARTHRALGIA 5
43 BLISTER 5
44 DECREASED APPETITE 5
45 HYPERTENSION 5
46 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5
47 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5
48 SENSITIVE SKIN 5
49 SKIN EXFOLIATION 5
50 SWELLING 5
51 XEROSIS 5
52 ABDOMINAL PAIN 4
53 ANAEMIA 4
54 ANXIETY 4
55 APPLICATION SITE PAIN 4
56 ASCITES 4
57 ASTHENIA 4
58 BACTERIAL INFECTION 4
59 BLOOD PRESSURE INCREASED 4
60 COUGH 4
61 DIABETES MELLITUS 4
62 DRY EYE 4
63 DYSPHAGIA 4
64 ECZEMA 4
65 NEURALGIA 4
66 PAIN OF SKIN 4
67 PULMONARY EMBOLISM 4
68 SKIN BURNING SENSATION 4
69 SKIN CANCER 4
70 SKIN IRRITATION 4
71 SLEEP DISORDER 4
72 SYNCOPE 4
73 THERAPEUTIC RESPONSE UNEXPECTED 4
74 VISUAL IMPAIRMENT 4
75 WEIGHT DECREASED 4
76 ABDOMINAL DISCOMFORT 3
77 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3
78 ADVERSE EVENT 3
79 ALLERGIC REACTION TO EXCIPIENT 3
80 ALLERGY TO CHEMICALS 3
81 BLOOD CHOLESTEROL INCREASED 3
82 BURNING SENSATION 3
83 CHEILITIS 3
84 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3
85 CONFUSIONAL STATE 3
86 CONSTIPATION 3
87 HEART RATE INCREASED 3
88 HOSPITALISATION 3
89 HYPERHIDROSIS 3
90 ILLNESS 3
91 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3
92 INSOMNIA 3
93 JOINT SWELLING 3
94 LUNG DISORDER 3
95 LUNG NEOPLASM MALIGNANT 3
96 MIGRAINE 3
97 MOOD ALTERED 3
98 MUSCLE SPASMS 3
99 NEOPLASM MALIGNANT 3
100 PIGMENTATION DISORDER 3
101 PNEUMONIA 3
102 PRODUCT COMPLAINT 3
103 PRODUCT USE IN UNAPPROVED INDICATION 3
104 PYREXIA 3
105 RASH MACULO-PAPULAR 3
106 RASH PAPULAR 3
107 SKIN DISCOLOURATION 3
108 SKIN HYPERPIGMENTATION 3
109 SKIN LESION 3
110 TACHYCARDIA 3
111 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
112 THROMBOSIS 3
113 TINNITUS 3
114 UNDERDOSE 3
115 VOMITING 3
116 ABNORMAL LOSS OF WEIGHT 2
117 ACNE CYSTIC 2
118 ACTINIC KERATOSIS 2
119 ALLERGY TO METALS 2
120 ALOPECIA 2
121 ANAL FISTULA 2
122 ANAPHYLACTIC REACTION 2
123 APPENDICITIS 2
124 APPENDICOLITH 2
125 APPLICATION SITE DISCHARGE 2
126 APPLICATION SITE DISCOLOURATION 2
127 APPLICATION SITE EXFOLIATION 2
128 ASPARTATE AMINOTRANSFERASE INCREASED 2
129 BACK PAIN 2
130 BACTEROIDES INFECTION 2
131 BLOOD GLUCOSE INCREASED 2
132 BLOOD PHOSPHORUS INCREASED 2
133 BLOOD URIC ACID INCREASED 2
134 BLOOD URINE PRESENT 2
135 BRONCHIECTASIS 2
136 BURSITIS 2
137 CANDIDA INFECTION 2
138 CARDIOGENIC SHOCK 2
139 CEREBROVASCULAR ACCIDENT 2
140 CHOLECYSTITIS ACUTE 2
141 CHOLESTASIS 2
142 CONTUSION 2
143 COVID-19 2
144 DEHYDRATION 2
145 DERMATITIS CONTACT 2
146 DIVERTICULITIS 2
147 DIVERTICULUM INTESTINAL 2
148 DYSPEPSIA 2
149 EYE IRRITATION 2
150 EYE PAIN 2
151 FALL 2
152 FEBRILE BONE MARROW APLASIA 2
153 FEELING ABNORMAL 2
154 FREQUENT BOWEL MOVEMENTS 2
155 GASTROINTESTINAL HAEMORRHAGE 2
156 GENERAL PHYSICAL HEALTH DETERIORATION 2
157 GOUT 2
158 HYPERLIPIDAEMIA 2
159 HYPERPHOSPHATAEMIA 2
160 HYPERTHYROIDISM 2
161 HYPOPHOSPHATAEMIA 2
162 IMMUNE SYSTEM DISORDER 2
163 IMMUNE-MEDIATED HEPATITIS 2
164 INFECTION 2
165 INFLAMMATION 2
166 INFLUENZA LIKE ILLNESS 2
167 INJECTION SITE PAIN 2
168 INTENTIONAL PRODUCT USE ISSUE 2
169 INTENTIONAL UNDERDOSE 2
170 IRON DEFICIENCY 2
171 LENTIGO 2
172 LIP OEDEMA 2
173 LOCALISED OEDEMA 2
174 LOWER RESPIRATORY TRACT INFECTION 2
175 MELANOCYTIC NAEVUS 2
176 MILIARIA 2
177 MIOSIS 2
178 MOBILITY DECREASED 2
179 MYALGIA 2
180 MYASTHENIA GRAVIS 2
181 OEDEMA 2
182 OEDEMA PERIPHERAL 2
183 OSTEOMYELITIS 2
184 OVERDOSE 2
185 PALPITATIONS 2
186 PERIPHERAL SWELLING 2
187 POLLAKIURIA 2
188 POLYP 2
189 PRESBYACUSIS 2
190 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2
191 PRODUCT DOSE OMISSION ISSUE 2
192 PRODUCT QUALITY ISSUE 2
193 PRODUCT STORAGE ERROR 2
194 PSORIATIC ARTHROPATHY 2
195 REACTION TO DRUG EXCIPIENTS 2
196 ROTATOR CUFF SYNDROME 2
197 SEBORRHOEIC KERATOSIS 2
198 SEIZURE 2
199 SEPSIS 2
200 SKIN HAEMORRHAGE 2
201 SKIN WARM 2
202 SQUAMOUS CELL CARCINOMA 2
203 STRESS 2
204 SUSPECTED COVID-19 2
205 TENDONITIS 2
206 TROPONIN INCREASED 2
207 TYPE 2 DIABETES MELLITUS 2
208 ULCER 2
209 UTERINE LEIOMYOMA 2
210 VAGINAL DISORDER 2
211 ACCIDENTAL EXPOSURE TO PRODUCT 1
212 ACIDOSIS 1
213 ACUTE KIDNEY INJURY 1
214 ACUTE PULMONARY OEDEMA 1
215 ADDISON^S DISEASE 1
216 ALANINE AMINOTRANSFERASE INCREASED 1
217 AMMONIA INCREASED 1
218 ANAL ABSCESS 1
219 ANGIOEDEMA 1
220 ANGIOPATHY 1
221 AORTIC STENOSIS 1
222 APLASIA 1
223 APPLICATION SITE HAEMORRHAGE 1
224 APPLICATION SITE IRRITATION 1
225 APPLICATION SITE NODULE 1
226 APPLICATION SITE PRURITUS 1
227 APPLICATION SITE RASH 1
228 APPLICATION SITE SCAB 1
229 APPLICATION SITE SWELLING 1
230 APPLICATION SITE VESICLES 1
231 ARTHROPOD STING 1
232 ASPIRATION 1
233 ASTHMA 1
234 ATRIAL FIBRILLATION 1
235 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1
236 BACK DISORDER 1
237 BALANCE DISORDER 1
238 BLOOD ALBUMIN DECREASED 1
239 BLOOD CALCIUM INCREASED 1
240 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
241 BLOOD PHOSPHORUS DECREASED 1
242 BLOOD PRESSURE DECREASED 1
243 BODY HEIGHT DECREASED 1
244 BONE MARROW FAILURE 1
245 BOWEL MOVEMENT IRREGULARITY 1
246 BRONCHOSPASM 1
247 C-REACTIVE PROTEIN 1
248 CARDIAC FAILURE CONGESTIVE 1
249 CARDIAC MURMUR 1
250 CARDIOMEGALY 1
251 CATARACT OPERATION 1
252 CENTRAL NERVOUS SYSTEM LYMPHOMA 1
253 CHEMICAL BURN 1
254 CHEMICAL BURNS OF EYE 1
255 CHOKING SENSATION 1
256 COLITIS 1
257 CONJUNCTIVITIS ALLERGIC 1
258 CONTRAINDICATED PRODUCT ADMINISTERED 1
259 CONVULSION 1
260 CROSS SENSITIVITY REACTION 1
261 CYTOKINE RELEASE SYNDROME 1
262 DERMATITIS ATOPIC 1
263 DERMATITIS PSORIASIFORM 1
264 DISABILITY 1
265 DISCOMFORT 1
266 DISEASE PROGRESSION 1
267 DISEASE RECURRENCE 1
268 DISTURBANCE IN ATTENTION 1
269 DROOLING 1
270 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
271 DRUG EFFECT INCOMPLETE 1
272 DRUG EFFECT LESS THAN EXPECTED 1
273 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
274 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
275 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
276 DYSPNOEA EXERTIONAL 1
277 EMOTIONAL DISTRESS 1
278 ENCEPHALITIS 1
279 END STAGE RENAL DISEASE 1
280 ENDOMETRIOSIS 1
281 EPISTAXIS 1
282 EXPIRED PRODUCT ADMINISTERED 1
283 EXPOSURE TO MOULD 1
284 EYE OEDEMA 1
285 FACE OEDEMA 1
286 FACIAL ASYMMETRY 1
287 FEBRILE NEUTROPENIA 1
288 FEELING HOT 1
289 FLATULENCE 1
290 FLUSHING 1
291 FOLLICULITIS 1
292 FUNGAL OESOPHAGITIS 1
293 GAIT DISTURBANCE 1
294 GASTRIC ULCER 1
295 GASTROENTERITIS VIRAL 1
296 GASTROINTESTINAL DISORDER 1
297 GASTROINTESTINAL MELANOSIS 1
298 GINGIVAL SWELLING 1
299 GLOSSODYNIA 1
300 GLYCOSURIA 1
301 GUTTATE PSORIASIS 1
302 HAEMANGIOMA 1
303 HAEMATOCHEZIA 1
304 HAEMATURIA 1
305 HAEMOGLOBIN DECREASED 1
306 HAEMORRHAGE 1
307 HAIR COLOUR CHANGES 1
308 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1
309 HEPATITIS 1
310 HERPES ZOSTER 1
311 HOT FLUSH 1
312 HYPERAESTHESIA 1
313 HYPERCREATININAEMIA 1
314 HYPEREOSINOPHILIC SYNDROME 1
315 HYPERGLYCAEMIA 1
316 HYPERKERATOSIS 1
317 HYPERSOMNIA 1
318 HYPERTRIGLYCERIDAEMIA 1
319 HYPOAESTHESIA 1
320 HYPOAESTHESIA ORAL 1
321 HYPOFERRITINAEMIA 1
322 HYPONATRAEMIA 1
323 HYPOPHAGIA 1
324 HYPOTENSION 1
325 HYPOTHYROIDISM 1
326 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1
327 IMMUNODEFICIENCY 1
328 IMMUNOSUPPRESSION 1
329 IMPAIRED QUALITY OF LIFE 1
330 INCORRECT DOSAGE ADMINISTERED 1
331 INCORRECT DOSE ADMINISTERED 1
332 INCORRECT DRUG ADMINISTRATION DURATION 1
333 INCORRECT PRODUCT ADMINISTRATION DURATION 1
334 INCORRECT PRODUCT STORAGE 1
335 INJECTION SITE DRYNESS 1
336 INJECTION SITE HAEMORRHAGE 1
337 INJECTION SITE MASS 1
338 INJECTION SITE PRURITUS 1
339 INJECTION SITE REACTION 1
340 INJECTION SITE SWELLING 1
341 INJURY ASSOCIATED WITH DEVICE 1
342 INTENTIONAL DOSE OMISSION 1
343 IRRITABILITY 1
344 JAUNDICE 1
345 JOINT WARMTH 1
346 LACRIMATION INCREASED 1
347 LEUKOPENIA 1
348 LIP DRY 1
349 LIP ERYTHEMA 1
350 LIVER FUNCTION TEST INCREASED 1
351 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
352 LOW DENSITY LIPOPROTEIN INCREASED 1
353 LYMPHOCYTE COUNT DECREASED 1
354 MALIGNANT MELANOMA IN SITU 1
355 MENINGITIS VIRAL 1
356 METASTATIC MALIGNANT MELANOMA 1
357 MOUTH ULCERATION 1
358 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
359 MUSCLE DISORDER 1
360 MUSCULAR WEAKNESS 1
361 MUSCULOSKELETAL DISCOMFORT 1
362 MUSCULOSKELETAL PAIN 1
363 MUSCULOSKELETAL STIFFNESS 1
364 MYELOSUPPRESSION 1
365 NAIL DISORDER 1
366 NASAL CONGESTION 1
367 NASAL OEDEMA 1
368 NASOPHARYNGITIS 1
369 NEPHROLITHIASIS 1
370 NERVE INJURY 1
371 NERVOUS SYSTEM DISORDER 1
372 NEUTROPENIA 1
373 NEUTROPHIL COUNT DECREASED 1
374 NODULE 1
375 OCULAR HYPERAEMIA 1
376 OCULAR ICTERUS 1
377 OESOPHAGEAL ULCER 1
378 OESOPHAGITIS 1
379 ORGANISING PNEUMONIA 1
380 OROPHARYNGEAL PAIN 1
381 OXYGEN SATURATION DECREASED 1
382 PANCREATIC CYST 1
383 PANCYTOPENIA 1
384 PARAESTHESIA 1
385 PERIPHERAL COLDNESS 1
386 PETECHIAE 1
387 PHARYNGEAL OEDEMA 1
388 PHARYNGITIS 1
389 PINGUECULA 1
390 PLASMA CELL MYELOMA 1
391 POOR QUALITY PRODUCT ADMINISTERED 1
392 PRE-EXISTING CONDITION IMPROVED 1
393 PRODUCT ADMINISTRATION INTERRUPTED 1
394 PRODUCT DOSE OMISSION 1
395 PRODUCT LOT NUMBER ISSUE 1
396 PRODUCTIVE COUGH 1
397 PROTEINURIA 1
398 PSYCHOTIC DISORDER 1
399 PULMONARY HAEMORRHAGE 1
400 PYOGENIC GRANULOMA 1
401 RALES 1
402 RASH MORBILLIFORM 1
403 RASH PRURITIC 1
404 RASH PUSTULAR 1
405 RECTAL HAEMORRHAGE 1
406 RED BLOOD CELL COUNT INCREASED 1
407 RENAL DISORDER 1
408 RESPIRATORY DISORDER 1
409 RESPIRATORY FAILURE 1
410 RETINAL HAEMORRHAGE 1
411 SCAB 1
412 SCAR 1
413 SCLERODERMA 1
414 SCRATCH 1
415 SEBORRHOEIC DERMATITIS 1
416 SELF-INJURIOUS IDEATION 1
417 SEPTIC SHOCK 1
418 SKIN ATROPHY 1
419 SKIN DEPIGMENTATION 1
420 SKIN DISCOMFORT 1
421 SKIN DISORDER 1
422 SKIN MASS 1
423 SKIN PLAQUE 1
424 SKIN REACTION 1
425 SKIN TIGHTNESS 1
426 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
427 SOCIOECONOMIC PRECARITY 1
428 SOLAR DERMATITIS 1
429 SPINAL DISORDER 1
430 SPUTUM DISCOLOURED 1
431 STOMATITIS 1
432 SUICIDAL IDEATION 1
433 SYSTEMIC LUPUS ERYTHEMATOSUS 1
434 TACHYPNOEA 1
435 THERAPEUTIC PRODUCT INEFFECTIVE 1
436 THERAPEUTIC RESPONSE SHORTENED 1
437 THIRST 1
438 THROMBOCYTOPENIA 1
439 THYROID CANCER 1
440 TONGUE ULCERATION 1
441 TONSILLITIS 1
442 TOOTH REPAIR 1
443 TOXIC SKIN ERUPTION 1
444 TRIGGER FINGER 1
445 UNDERWEIGHT 1
446 UPPER RESPIRATORY TRACT INFECTION 1
447 URINARY INCONTINENCE 1
448 URINARY RETENTION 1
449 VASCULAR INJURY 1
450 VASCULITIS 1
451 VENTRICULAR DYSFUNCTION 1
452 VENTRICULAR FIBRILLATION 1
453 VERTIGO 1
454 VISION BLURRED 1
455 VITILIGO 1
456 VITREOUS HAEMORRHAGE 1
457 VON WILLEBRAND^S DISEASE 1
458 WALKING DISABILITY 1
459 WEIGHT INCREASED 1
460 WHITE BLOOD CELL COUNT DECREASED 1
461 WOUND 1